**Reynold Braude Phenomenon**
==========================

### Core Concept
Reynold Braude phenomenon is a laboratory finding that occurs in the presence of certain anticoagulants, particularly heparin, which can lead to the formation of a gel-like substance in plasma.

### Why the Correct Answer is Right
The Reynold Braude phenomenon is characterized by the formation of a gel-like substance in plasma due to the interaction between heparin and the fibrinogen molecule. This occurs because heparin accelerates the conversion of fibrinogen to fibrin, resulting in the formation of a stable fibrin gel. This phenomenon is often observed in patients receiving heparin therapy, particularly when it is used in conjunction with other anticoagulants.

### Why Each Wrong Option is Incorrect
**Option A:** This option is not relevant to the Reynold Braude phenomenon, as it is not associated with the use of heparin or the formation of a gel-like substance in plasma.
**Option B:** This option is incorrect because it is not directly related to the Reynold Braude phenomenon, which is a specific laboratory finding associated with heparin therapy.
**Option C:** This option is not correct because it is a different laboratory finding altogether, unrelated to the Reynold Braude phenomenon.

### Clinical Pearl / High-Yield Fact
When administering heparin to patients, it is essential to monitor for signs of the Reynold Braude phenomenon, such as the formation of a gel-like substance in plasma. This can be done by performing a plasma clotting time (PCT) or a heparin-induced thrombocytopenia (HIT) assay.

### Correct Answer:
(Insert the correct answer letter here)
Heparin